This company listing is no longer active
このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Sproutly Canada マネジメント
マネジメント 基準チェック /24
主要情報
Arup Sen
最高経営責任者
n/a
報酬総額
CEO給与比率 | n/a |
CEO在任期間 | 4.3yrs |
CEOの所有権 | n/a |
経営陣の平均在職期間 | 4.4yrs |
取締役会の平均在任期間 | 2.9yrs |
経営陣の近況
更新なし
Recent updates
CEO報酬分析
日付 | 総報酬 | 給与 | 会社業績 |
---|---|---|---|
Nov 30 2021 | n/a | n/a | -CA$14m |
Aug 31 2021 | n/a | n/a | -CA$13m |
May 31 2021 | n/a | n/a | -CA$15m |
Feb 28 2021 | CA$100k | CA$100k | -CA$16m |
Nov 30 2020 | n/a | n/a | -CA$59m |
Aug 31 2020 | n/a | n/a | -CA$59m |
May 31 2020 | n/a | n/a | -CA$61m |
Feb 29 2020 | CA$182k | CA$182k | -CA$62m |
Nov 30 2019 | n/a | n/a | -CA$12m |
Aug 31 2019 | n/a | n/a | -CA$12m |
May 31 2019 | n/a | n/a | -CA$14m |
Feb 28 2019 | CA$121k | CA$121k | -CA$13m |
報酬と市場: Insufficient data to establish whether Arup's total compensation is reasonable compared to companies of similar size in the German market.
報酬と収益: Arup's compensation has been consistent with company performance over the past year.
CEO(最高経営責任者
Arup Sen
4.3yrs
在職期間
CA$100,000
報酬
Dr. Arup Sen, PhD has been Chief Executive Officer at Sproutly Canada Inc. since May 14, 2020 and serves as it's Chairman since August, 2020. Dr. Sen serves as the Chief Executive Officer of Infusion Biosc...
リーダーシップ・チーム
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
Chairman | 4.3yrs | CA$100.00k | データなし | |
CFO, Corporate Secretary & Director | 4.4yrs | CA$102.40k | 0.021% € 1.1k | |
Strategic Advisor to Chairman of the Board of Directors | 2.6yrs | CA$23.11k | データなし | |
Chief Operating Officer | 4.4yrs | CA$141.87k | データなし |
4.4yrs
平均在職期間
経験豊富な経営陣: 38G's management team is considered experienced (4.4 years average tenure).
取締役
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
Chairman | 4.3yrs | CA$100.00k | データなし | |
CFO, Corporate Secretary & Director | 2.5yrs | CA$102.40k | 0.021% € 1.1k | |
Independent Director | 3.3yrs | データなし | データなし | |
Independent Director | 2.4yrs | データなし | データなし |
2.9yrs
平均在職期間
経験豊富なボード: 38G's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.